Results 61 to 70 of about 16,307 (145)
ABSTRACT Rare adverse drug reactions (ADRs) are underrecognized and underreported in the electronic medical record (EMR). These events often require clinical review, making systematic identification challenging. The study aim was to develop an approach to prioritize identification and validation of a rare ADR to trimethoprim‐sulfamethoxazole causing ...
Keith Feldman +6 more
wiley +1 more source
POST OPERATIVE STEVEN JOHNSON TYPE REACTION SECONDARY TO PIPERACILLIN
Toxic epidermal necrolysis (TEN) and Stevens–Johnson syndrome (SJS) are lethal cutaneous reactions to medications stirring1–2 per million individuals every year.
Dr. Anam Liaqat +2 more
doaj +2 more sources
Ivermectin induced Steven–Johnsons syndrome: case report
Background Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as ...
Desmond Aroke +5 more
doaj +1 more source
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan +17 more
wiley +1 more source
Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
Introduction: Topical imiquimod is a safe and effective treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. The treatment is commonly associated with local inflammatory reactions, while systemic side effects are rare
Ilaria Salvi +4 more
doaj +1 more source
Relationships of CSF biomarkers to cortical atrophy in early‐onset Alzheimer's disease
Abstract INTRODUCTION Although cerebrospinal fluid (CSF) biomarkers reflect neurodegeneration in Alzheimer's disease (AD), it remains unclear whether these biomarkers track neurodegeneration in early‐onset Alzheimer's disease (EOAD). METHODS In 80 EOAD patients, we examined correlations between eight CSF biomarker levels and cortical thickness ...
Alexandra Touroutoglou +48 more
wiley +1 more source
Aim To evaluate the effects of carbamazepine, a strong cytochrome P450 (CYP)3A4 inducer, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader. Methods This was a phase 1, open‐label, fixed‐sequence, two‐period study in healthy adult participants.
Hechuan Wang +7 more
wiley +1 more source
Stevens-Johnson induced by imiquimod 5% cream: a case report
Imiquimod 5% cream is an approved treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. Severe systemic side effects associated to imiquimod 5% cream are rare, although few cases of erythema multiforme and Stevens ...
Ilaria Trave +5 more
doaj +1 more source
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway +24 more
wiley +1 more source
Applying the Social Identity Approach to Leadership to Online Support Groups for Long Covid
ABSTRACT Previous research has shown that online support groups for Long Covid may improve group members' wellbeing, but there is limited evidence on the role of group moderators in influencing such outcomes. Applying the social identity approach to leadership, this study sought to understand the extent to which group moderators display identity ...
Freya Mills +5 more
wiley +1 more source

